Novan to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

Rhea-AI Summary

Novan, Inc. (Nasdaq: NOVN) announced a presentation by President and CEO Paula Brown Stafford at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020, at 4:00 PM EDT. The conference will feature virtual one-on-one meetings for registered investors. A live video webcast of the presentation will be accessible on Novan's investor website, with a replay available two hours post-event and archived for 90 days. Novan focuses on developing nitric oxide-based treatments for various diseases, including dermatology and women’s health.

- Live video webcast with President and CEO, Paula Brown Stafford, on Monday, September 14^th at 4:00 PM EDT -

MORRISVILLE, N.C., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq: NOVN), today announced that Paula Brown Stafford, Chairman, President and Chief Executive Officer of Novan will present at the H.C. Wainwright 22^nd Annual Global Investment Conference on Monday, September 14, 2020 at 4:00 PM EDT.

In addition to the presentation, management will also be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information, please visit the conference website here.

A live video webcast of the presentation will be available on the Events page of the Investors section of the Company’s website (novan.com). The video webcast replay will be made available two hours following the event and will be archived for 90 days.

About Novan

Novan, Inc. is a clinical development-stage biotechnology company focused on leveraging nitric oxide’s naturally occurring anti-microbial and immunomodulatory mechanisms of action to treat a range of diseases with significant unmet needs. We believe that our ability to deploy nitric oxide in a solid form, on demand and in localized formulations allows us the potential to improve patient outcomes in a variety of dermatology, women’s health and gastrointestinal diseases.

INVESTOR AND MEDIA CONTACT:

Jenene Thomas
JTC Team, LLC
833-475-8247
NOVN@jtcir.com

FAQ

What is Novan presenting at the H.C. Wainwright 22nd Annual Global Investment Conference?

Novan will present on September 14, 2020, at 4:00 PM EDT, focusing on their nitric oxide-based treatments.

How can I watch Novan's presentation at the investment conference?

A live video webcast of Novan's presentation will be available on their investor website.

When will the replay of Novan's conference presentation be available?

The replay will be accessible two hours after the event and archived for 90 days.

Who is the CEO of Novan?

Paula Brown Stafford is the President and CEO of Novan.

What is Novan's focus in biotechnology?

Novan focuses on utilizing nitric oxide for treating various diseases with unmet needs.